Published in Eur J Surg Oncol on June 01, 2000
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
Evolutionary dynamics of cancer in response to targeted combination therapy. Elife (2013) 2.76
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation. Radiat Environ Biophys (2009) 1.14
Activated lymphocytes as a metabolic model for carcinogenesis. Cancer Metab (2013) 1.07
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib. Br J Cancer (2009) 0.95
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J Clin Pathol (2004) 0.89
The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling. J Math Biol (2003) 0.86
Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways. World J Gastroenterol (2004) 0.85
Cell cycle times of short-term cultures of brain cancers as predictors of survival. Br J Cancer (2008) 0.85
Early and multiple origins of metastatic lineages within primary tumors. Proc Natl Acad Sci U S A (2016) 0.84
Modeling progression in radiation-induced lung adenocarcinomas. Radiat Environ Biophys (2010) 0.82
Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits. Clin Oncol (R Coll Radiol) (2015) 0.81
Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability. Med Phys (2013) 0.78
A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample. BMC Cancer (2005) 0.78
Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time. Br J Radiol (2013) 0.76
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer. Onco Targets Ther (2016) 0.75
Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity. Chem Cent J (2012) 0.75
Optimal MRI interval for detection of asymptomatic recurrence in surgically treated early cervical cancer by use of a mathematical model. Hippokratia (2016) 0.75
A role for Rtt109 in buffering gene-dosage imbalance during DNA replication. Nucleus (2016) 0.75
Timed, sequential administration of paclitaxel improves its cytotoxic effectiveness in a cell culture model. Cell Cycle (2016) 0.75
Alteration of cellular metabolism in cancer cells and its therapeutic prospects. J Oral Maxillofac Pathol (2017) 0.75
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res (2000) 5.74
An SNP map of human chromosome 22. Nature (2000) 2.99
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93
A new measure of conservatism. Br J Soc Clin Psychol (1968) 1.87
Determination of continuing medical education needs of clinicians from a literature search study, Part I. The study. Bull Med Libr Assoc (1977) 1.83
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys (1995) 1.77
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry (1985) 1.71
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer (2003) 1.57
Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg (1991) 1.55
Efficacy of chromium supplementation in athletes: emphasis on anabolism. Int J Sport Nutr (1992) 1.49
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer (2005) 1.45
A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma. J Plast Reconstr Aesthet Surg (2007) 1.41
Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Br J Surg (1997) 1.38
Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord (2004) 1.24
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer (1992) 1.24
Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer (1991) 1.11
Advances in cell kinetics. BMJ (1991) 1.05
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
A review of factors affecting blood biochemistry in the pig. Br Vet J (1972) 1.04
Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem (1992) 1.00
Social and psychological factors in the distribution of STD in male clinic attenders. I Demographic and social factors. Br J Vener Dis (1983) 0.99
Sexual orientation and the 2nd to 4th finger length ratio: evidence for organising effects of sex hormones or developmental instability? Psychoneuroendocrinology (2003) 0.99
Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg (1992) 0.99
Comparison of the BOD POD with the four-compartment model in adult females. Med Sci Sports Exerc (2001) 0.96
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol (1999) 0.95
Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys (1997) 0.95
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg (1998) 0.93
Social and psychological factors in the distribution of STD in male clinic attenders. II Personality disorders, psychiatric illness, and abnormal sexual attitudes. Br J Vener Dis (1983) 0.90
An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer (1993) 0.89
A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res (1999) 0.89
Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer (1993) 0.89
Bcl-2 expression in malignant melanoma and its prognostic significance. Eur J Surg Oncol (1996) 0.88
Cell kinetics of mouse kidney using bromodeoxyuridine incorporation and flow cytometry: preparation and staining. Cell Tissue Kinet (1987) 0.88
Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. Br J Plast Surg (1997) 0.88
C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. Eur J Surg Oncol (1996) 0.88
Modulation of the acoustic startle reflex by emotionally-toned film-clips. Int J Psychophysiol (1999) 0.88
Alterations in dietary carbohydrate, protein, and fat intake and mood state in trained female cyclists. Med Sci Sports Exerc (1991) 0.87
Cellular proliferation characteristics do not account for the behaviour of horrifying basal cell carcinoma. A comparison of the growth fraction of horrifying and non horrifying tumours. Br J Plast Surg (1998) 0.87
Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. Eur J Surg Oncol (2000) 0.86
The prognostic significance of c-myc oncogene expression in uveal melanoma. Melanoma Res (1998) 0.86
Is Dupuytren's disease caused by an imbalance between proliferation and cell death? J Hand Surg Br (1999) 0.86
Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. J Plast Reconstr Aesthet Surg (2007) 0.86
Effects of varying concentrations of N2/O2 and He/O2 on exercise tolerance in man. Med Sci Sports Exerc (1980) 0.86
Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer (1994) 0.85
Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int J Radiat Oncol Biol Phys (1992) 0.85
Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks. Radiat Res (2006) 0.85
The physiologic effects of eight weeks of aerobic dance with and without hand-held weights. Am J Sports Med (1987) 0.85
Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys (1997) 0.84
Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells. Leuk Res (1991) 0.84
The clinical significance of c-myc oncogene expression in melanomas of the scalp. Br J Plast Surg (1998) 0.84
Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys (1992) 0.83
The effect of the squat exercise on knee stability. Med Sci Sports Exerc (1989) 0.83
Human alpha-lactalbumin and hormonal factors in pregnancy and lactation. Clin Endocrinol (Oxf) (1980) 0.83
Parental characteristics and partner choice: some evidence for oedipal imprinting. J Biosoc Sci (1987) 0.82
Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis. Clin Endocrinol (Oxf) (1981) 0.82
1-Naphthol: a potential selective antitumour agent. Biochem Pharmacol (1983) 0.82
Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours. Cytometry (1995) 0.82
Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma. Br J Plast Surg (1999) 0.82
Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding. Biochem Pharmacol (1991) 0.82
Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors. Cytometry (1998) 0.81
Selective toxicity of 1-naphthol to human colorectal tumour tissue. Br J Cancer (1985) 0.81
Fluorescent markers for hypoxic cells: a study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive binding. J Med Chem (1991) 0.81
Effects of hyperoxic gas mixtures on exercise tolerance in man. Med Sci Sports (1975) 0.81
Conservatism and art preferences. J Pers Soc Psychol (1973) 0.81
Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol (1988) 0.81
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. Br J Cancer (1998) 0.80
Labelling index of gynaecological tumours assessed by bromodeoxyuridine staining in vitro using flow cytometry and histochemistry. Int J Radiat Biol (1989) 0.80
c-myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours. Br J Surg (1991) 0.80
Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines. Eur J Cancer (2002) 0.80
Cell kinetics of normal and perturbed populations measured by incorporation of bromodeoxyuridine and flow cytometry. Br J Radiol (1986) 0.80
Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study. Br J Urol (1991) 0.80
An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma. Br J Plast Surg (2000) 0.80
Flow cytometric study of nodular fasciitis, proliferative fasciitis, and proliferative myositis. Hum Pathol (1991) 0.80
Effects of varying recovery periods on muscle enzymes, soreness, and performance in baseball pitchers. J Athl Train (1992) 0.79
The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma. Br J Plast Surg (2002) 0.79
Efficient in vivo targeting of malignant melanoma by single-chain Fv antibody fragments. Melanoma Res (1999) 0.79
The prognostic importance of c-myc oncogene expression in head and neck melanoma. Ann Plast Surg (2001) 0.79
The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model. Br J Cancer (2006) 0.79
The potential benefit from individualised radiotherapy scheduling for head and neck tumours on the basis of both histological grade and kinetics. Radiother Oncol (1999) 0.79
Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture. Cancer Res (1980) 0.78
Flow cytometric analysis of protein thiol groups in relation to the cell cycle and the intracellular content of glutathione in rat hepatocytes. Cytometry (1989) 0.78
The clinical significance of oncogene expression in subungual melanoma. Br J Plast Surg (1997) 0.78
Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node. J Exp Clin Cancer Res (2007) 0.78
Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma. Eur J Surg Oncol (2005) 0.78
Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. Radiother Oncol (1999) 0.78
The relation between c-myc expression and interferon sensitivity in uveal melanoma. Br J Ophthalmol (2004) 0.78
An analysis of p16 protein expression in sporadic malignant melanoma. Melanoma Res (1998) 0.78
Reporting basal cell carcinoma: a survey of the attitudes of histopathologists. J Clin Pathol (1999) 0.78
A test to estimate VO2max in females using aerobic dance, heart rate, BMI, and age. J Sports Med Phys Fitness (1995) 0.78
Cell proliferation and differentiation in squamous cancer. Radiother Oncol (1989) 0.77
Resistive training and selected effects. Med Clin North Am (1985) 0.77
Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg (2000) 0.77
Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine. Melanoma Res (2002) 0.77
Reversal of differential GSR conditioning by instructions. J Exp Psychol (1968) 0.77
Individual differences in tapping performance as a function of time on the task. Percept Mot Skills (1971) 0.77
Cardiovascular responses to short-term olympic style weight-training in young men. Can J Appl Sport Sci (1983) 0.76
Effect of sodium butyrate on synthesis of specific proteins by human breast-carcinoma cells. Br J Cancer (1980) 0.76
Improved production by domain inversion of single-chain Fv antibody fragment against high molecular weight proteoglycan for the radioimmunotargeting of melanoma. Hybrid Hybridomics (2001) 0.76
GSR responses to fear-related stimuli. Percept Mot Skills (1967) 0.76